NOT-AI-24-043: Notice of Change in the NIAID K24 Allowable Application Types and Eligibility Requirements

Notice of Change in the NIAID K24 Allowable Application Types and Eligibility Requirements

Notice Number:

NOT-AI-24-043

Key Dates

Release Date:

May 7, 2024

Related Announcements

April 25, 2024 – Midcareer Investigator Award in Patient Oriented Research (Parent K24 Independent Clinical Trial Not Allowed). See NOFO PA-24-188.
April 25, 2024 - Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Required). See NOFO PA-24-187.

Issued by

National Institute of Allergy and Infectious Diseases (NIAID)

Purpose

Effective for application due dates on or after June 12, 2024, NIAID will no longer accept renewal (Type 2) applications through the following notices of funding opportunities (NOFOs) or any reissues:Midcareer Investigator Award in Patient Oriented Research (Parent K24 Independent Clinical Trial Not Allowed) and Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Required).

Additionally, NIAID will not accept applications from full professors. At the time of application, applicants should be mid-career faculty at the Associate Professor level or equivalent.

Inquiries

Please direct all inquiries to:

Jyothi Arikkath, PhD
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 301-594-5945
Email: [email protected]